Zelda Therapeutics partners with St Vincent’s Hospital for opioid reduction study
Zelda Therapeutics Ltd has expanded a human clinical trial program to use cannabinoid medications in patients on chronic, high dose opioid pain management therapy. This will see Zelda partner with St Vincent’s Hospital in Melbourne in a clinical trial partnership to examine the potential to use certain cannabinoid medications. The joint clinical trial program is … Read more
